Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04806607 · ClinicalTrials.gov registry record · NA

19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)

A NA study, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT04806607: Completed NA study, sponsored by Geisinger Clinic.

NCT04806607 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04806607, a NA study, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.

Primary Outcome

Length of the longest piece of the liver tissue obtained

Interventions

  • PROCEDURE 19G FNB
  • PROCEDURE 22G FNB

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2021-04-30
Est. Completion 2022-03-16
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT04806607 record still lists

NCT04806607 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which 19G FNB is the first listed.

NCT04806607 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04806607 about?

NCT04806607 is a clinical study titled "19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)". To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.

What is the current status of trial NCT04806607?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-04-30. Estimated completion is 2022-03-16.

What interventions are being tested in trial NCT04806607?

The interventions under investigation include: 19G FNB (PROCEDURE), 22G FNB (PROCEDURE).

Who is sponsoring clinical trial NCT04806607?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04806607's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04806607, the US trial registry maintained by the National Library of Medicine. NCT04806607 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.